This study is looking at how well a special inhaler works for people with Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung disease that makes it hard to breathe. The inhaler has three medicines: Budesonide, Glycopyrronium, and Formoterol Fumarate, which help open airways in the lungs. The study compares two treatments to see which one works better for heart and lung health. It is a Phase III study, meaning it's in a later stage of testing to make sure it's safe and effective.

Key Points:

• The study is for people aged 40-80 with COPD and heart risks. Participants need to be able to use the inhaler correctly and be ready to change their COPD medication if needed.
• Participants will visit the study site or have virtual visits for assessments. They need to stop some other medicines and not join another study at the same time.
• Women who can have children must use a reliable method to prevent pregnancy during the study.

It's important to be aware of certain health conditions like asthma, unstable heart disease, or recent lung cancer, as these may prevent participation in the study.